Authors:
Christ, O
Seiter, S
Matzku, S
Burger, C
Zoller, M
Citation: O. Christ et al., Efficacy of local versus systemic application of antibody-cytokine fusion proteins in tumor therapy, CLIN CANC R, 7(4), 2001, pp. 985-998
Authors:
Reinhold, U
Berkin, C
Bosserhoff, AK
Deutschmann, A
Garbe, C
Glaser, R
Hein, R
Krahn, G
Peter, RU
Rappl, G
Schittek, B
Seiter, S
Ugurel, S
Volkenandt, M
Tilgen, W
Citation: U. Reinhold et al., Interlaboratory evaluation of a new reverse transcriptase polymerase chainreaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: A multicenter study of the dermatologic cooperativeoncology group, J CL ONCOL, 19(6), 2001, pp. 1723-1727
Authors:
Hauschild, A
Garbe, C
Stolz, W
Ellwanger, U
Seiter, S
Dummer, R
Ugurel, S
Sebastian, G
Nashan, D
Linse, R
Achtelik, W
Mohr, P
Kaufmann, R
Fey, M
Ulrich, J
Tilgen, W
Citation: A. Hauschild et al., Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG), BR J CANC, 84(8), 2001, pp. 1036-1042
Citation: S. Seiter et al., The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities, INT IMMUNOL, 12(1), 2000, pp. 37-49
Authors:
Middleton, MR
Grob, JJ
Aaronson, N
Fierlbeck, G
Tilgen, W
Seiter, S
Gore, M
Aamdal, S
Cebon, J
Coates, A
Dreno, B
Henz, M
Schadendorf, D
Kapp, A
Weiss, J
Fraass, U
Statkevich, P
Muller, M
Thatcher, N
Citation: Mr. Middleton et al., Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma, J CL ONCOL, 18(1), 2000, pp. 158-166
Authors:
Freyschmidt-Paul, P
Seiter, S
Zoller, M
Konig, A
Ziegler, A
Sundberg, JP
Happle, R
Hoffmann, R
Citation: P. Freyschmidt-paul et al., Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice, J INVES DER, 115(4), 2000, pp. 653-657
Authors:
Seiter, S
Ugurel, S
Tilgen, W
Reinhold, U
Citation: S. Seiter et al., Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo, INT J DERM, 39(8), 2000, pp. 624-627
Authors:
Naderi, S
Hormann, P
Seiter, S
Tilgen, W
Abken, H
Reinhold, U
Citation: S. Naderi et al., CD2-mediated CD59 stimulation in keratinocytes results in secretion of IL-1 alpha, IL-6, and GM-CSF: Implications for the interaction of keratinocytes with intraepidermal T lymphocytes, INT J MOL M, 3(6), 1999, pp. 609-614
Authors:
Seiter, S
Ugurel, S
Pfohler, C
Tilgen, W
Reinhold, U
Citation: S. Seiter et al., Successful treatment of progressive vitiligo with high-dose intravenous methylprednisolone 'pulse' therapy, DERMATOLOGY, 199(3), 1999, pp. 261-262
Authors:
Wurfel, J
Rosel, M
Seiter, S
Claas, C
Herlevsen, M
Weth, R
Zoller, M
Citation: J. Wurfel et al., Metastasis-association of the rat ortholog of the human epithelial glycoprotein antigen EGP314, ONCOGENE, 18(14), 1999, pp. 2323-2334
Citation: S. Seiter et al., Dynamics of soil fungal and bacterial biomass in a temperate climate alleycropping system, APPL SOIL E, 12(2), 1999, pp. 139-147
Authors:
Reinhold, U
Seiter, S
Ugurel, S
Tilgen, J
Citation: U. Reinhold et al., Treatment of progressive pigmented purpura with oral bioflavonoids and, ascorbic acid: An open pilot study in 3 patients, J AM ACAD D, 41(2), 1999, pp. 207-208
Citation: S. Seiter et Wr. Horwath, The fate of tree root and pruning nitrogen in a temperate climate alley cropping system determined by tree injected N-15, BIOL FERT S, 30(1-2), 1999, pp. 61-68
Citation: S. Seiter et al., Crop yield and tree-leaf production in three planting patterns of temperate-zone alley cropping in Oregon, USA, AGROFOR SYS, 46(3), 1999, pp. 273-288
Authors:
Wittig, B
Seiter, S
Schmidt, DS
Zuber, M
Neurath, M
Zoller, M
Citation: B. Wittig et al., CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases, LAB INV, 79(6), 1999, pp. 747-759
Citation: S. Seiter et al., Mitigation of delayed-type hypersensitivity reactions by a CD44 variant isoform v3-specific antibody: Blockade of leukocyte egress, J INVES DER, 113(1), 1999, pp. 11-21
Authors:
Ugurel, S
Seiter, S
Rappl, G
Stark, A
Tilgen, W
Reinhold, U
Citation: S. Ugurel et al., Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma, INT J CANC, 82(5), 1999, pp. 727-736